Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Waylivra (volanesorsen) 285 mg solution for injection in pre-filled syringe {equilateral_black_triangle}

Active Ingredient:
volanesorsen sodium
Company:  
Akcea Therapeutics UK Ltd See contact details
ATC code: 
C10AX18
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 12 Jul 2023

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Akcea Therapeutics UK Ltd
Company image
Address
1st Floor West, Davidson House, Forbury Square, Reading, Berkshire, RG1 3EU, UK
Medical Information Direct Line
+44 (0) 800 111 4754
Medical Information e-mail
[email protected]